TSVT - 2seventy bio, Inc.

2seventy bio, Inc.

TSVT

NASDAQ

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

4.98 USD

-0.01 (-0.201%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

238.15M

278.11M

296.62M

310.45M

Annual Depreciation

7.1M

10.29M

11.53M

16.4M

Capital Expenditure

-707k

-13.87M

-22.84M

-19.57M

Net PPE

231.76M

281.69M

307.93M

313.62M

All figures are in USD.

All Income Statement Balance Sheet Statement Cash Flow Statement Retained Earning Schedule PPE Schedule Intangible and Goodwill Schedule

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.